BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 22406943)

  • 1. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands.
    Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S
    Cornea; 2012 Nov; 31(11):1229-34. PubMed ID: 22406943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term topical anti-glaucoma medications on meibomian glands.
    Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Aihara M; Amano S
    Graefes Arch Clin Exp Ophthalmol; 2012 Aug; 250(8):1181-5. PubMed ID: 22349978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meibography of Eyes With Sequelae of Trachoma.
    AlDarrab A; Al-Faky YH; Mousa A; Alsuhaibani AH
    Cornea; 2018 Apr; 37(4):416-420. PubMed ID: 29504955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meibomian gland dropout in patients with dry eye disease in China.
    Feng Y; Gao Z; Feng K; Qu H; Hong J
    Curr Eye Res; 2014 Oct; 39(10):965-72. PubMed ID: 25051400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed diagnostic criteria for obstructive meibomian gland dysfunction.
    Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Fukuoka S; Tomidokoro A; Amano S
    Ophthalmology; 2009 Nov; 116(11):2058-63.e1. PubMed ID: 19744718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications.
    Uzunosmanoglu E; Mocan MC; Kocabeyoglu S; Karakaya J; Irkec M
    Cornea; 2016 Aug; 35(8):1112-6. PubMed ID: 27055218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed diagnostic criteria for seborrheic meibomian gland dysfunction.
    Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Amano S
    Cornea; 2010 Sep; 29(9):980-4. PubMed ID: 20628302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population.
    Arita R; Itoh K; Inoue K; Amano S
    Ophthalmology; 2008 May; 115(5):911-5. PubMed ID: 18452765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Morphological and Functional Meibomian Gland Characteristics Between Daily Contact Lens Wearers and Nonwearers.
    Machalińska A; Zakrzewska A; Adamek B; Safranow K; Wiszniewska B; Parafiniuk M; Machaliński B
    Cornea; 2015 Sep; 34(9):1098-104. PubMed ID: 26114822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes in the meibomian glands of patients with phlyctenular keratitis: a multicenter cross-sectional study.
    Suzuki T; Morishige N; Arita R; Koh S; Sakimoto T; Shirakawa R; Miyata K; Ohashi Y
    BMC Ophthalmol; 2016 Oct; 16(1):178. PubMed ID: 27724848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye.
    Arita R; Itoh K; Maeda S; Maeda K; Tomidokoro A; Amano S
    Jpn J Ophthalmol; 2010 Sep; 54(5):387-91. PubMed ID: 21052898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Meibomian Gland Dysfunction and Local Distribution of Meibomian Gland Atrophy by Non-contact Infrared Meibography.
    Finis D; Ackermann P; Pischel N; König C; Hayajneh J; Borrelli M; Schrader S; Geerling G
    Curr Eye Res; 2015; 40(10):982-9. PubMed ID: 25330304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meibomian gland dysfunction in longstanding prosthetic eye wearers.
    Jang SY; Lee SY; Yoon JS
    Br J Ophthalmol; 2013 Apr; 97(4):398-402. PubMed ID: 23322882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction.
    Mocan MC; Uzunosmanoglu E; Kocabeyoglu S; Karakaya J; Irkec M
    J Glaucoma; 2016 Sep; 25(9):770-4. PubMed ID: 27513901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical diquafosol for patients with obstructive meibomian gland dysfunction.
    Arita R; Suehiro J; Haraguchi T; Maeda S; Maeda K; Tokoro H; Amano S
    Br J Ophthalmol; 2013 Jun; 97(6):725-9. PubMed ID: 23584719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meibomian Gland Changes in Open-angle Glaucoma Users Treated with Topical Medication.
    Soriano D; Ferrandez B; Mateo A; Polo V; Garcia-Martin E
    Optom Vis Sci; 2021 Oct; 98(10):1177-1182. PubMed ID: 34678837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meibomian gland duct distortion in patients with perennial allergic conjunctivitis.
    Arita R; Itoh K; Maeda S; Maeda K; Furuta A; Tomidokoro A; Amano S
    Cornea; 2010 Aug; 29(8):858-60. PubMed ID: 20508507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma.
    Lee TH; Sung MS; Heo H; Park SW
    PLoS One; 2018; 13(1):e0191398. PubMed ID: 29385185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal effect of topical antiglaucoma medications on central corneal thickness.
    Viswanathan D; Goldberg I; Graham SL
    Clin Exp Ophthalmol; 2013; 41(4):348-54. PubMed ID: 22958109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.